Frontiers in Oncology,
Год журнала:
2021,
Номер
11
Опубликована: Дек. 1, 2021
Glioblastoma
represents
the
most
devastating
form
of
human
brain
cancer,
associated
with
a
very
poor
survival
rate
patients.
Unfortunately,
treatment
options
are
currently
limited
and
gold
standard
pharmacological
chemotherapeutic
drug
temozolomide
only
slightly
increases
rate.
Experimental
studies
have
shown
that
efficiency
can
be
improved
by
inducing
ferroptosis
–
recently
discovered
cell
death,
which
is
different
from
apoptosis,
necrosis,
or
necroptosis
and,
characterized
lipid
peroxidation
reactive
oxygen
species
accumulation.
Ferroptosis
also
activated
to
improve
malignant
stages
neuroblastoma,
meningioma,
glioma.
Due
their
role
in
cancer
treatment,
ferroptosis-gene
signatures
been
evaluated
for
ability
predict
Despite
positive
effects
during
chemotherapy,
drugs
used
induce
such
as
erastin
sorafenib
well
genetic
manipulation
key
players
cystine-glutamate
exchanger
xCT
glutathione
peroxidase
GPx4
impact
neuronal
function
cognitive
capabilities.
In
this
review,
we
give
an
update
on
tumors
summarize
healthy
tissues.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Ноя. 22, 2022
Immunotherapy
has
revolutionized
colon
cancer
treatment.
Immune
checkpoint
inhibitors
(ICIs)
have
shown
clinical
benefits
for
patients,
especially
those
with
high
microsatellite
instability
(MSI-H).
In
2020,
the
US
Food
and
Drug
Administration
(FDA)-approved
ICI
pembrolizumab
as
first-line
treatment
metastatic
MSI-H
patients.
Additionally,
neoadjuvant
immunotherapy
presented
efficacy
in
treating
early-stage
Although
MSI
been
thought
of
an
effective
predictive
biomarker
immunotherapy,
only
a
small
proportion
patients
were
MSI-H,
certain
intrinsic
or
acquired
resistance
to
immunotherapy.
Thus,
further
search
biomarkers
stratify
is
meaningful
Except
MSI,
other
biomarkers,
such
PD-L1
expression
level,
tumor
mutation
burden
(TMB),
tumor-infiltrating
lymphocytes
(TILs),
gut
microbiota,
ctDNA,
circulating
immune
cells
also
proposed
be
correlated
patient
survival
some
studies.
Moreover,
developing
new
diagnostic
techniques
helps
identify
accurate
this
review,
we
outline
reported
discuss
prospects
technological
changes
development
Journal of Experimental & Clinical Cancer Research,
Год журнала:
2024,
Номер
43(1)
Опубликована: Янв. 13, 2024
Abstract
Ferroptosis,
a
novel
form
of
cell
death
triggered
by
iron-dependent
phospholipid
peroxidation,
presents
significant
therapeutic
potential
across
diverse
cancer
types.
Central
to
cellular
metabolism,
the
metabolic
pathways
associated
with
ferroptosis
are
discernible
in
both
cancerous
and
immune
cells.
This
review
begins
delving
into
intricate
reciprocal
regulation
between
It
subsequently
details
how
factors
within
tumor
microenvironment
(TME)
such
as
nutrient
scarcity,
hypoxia,
density
modulate
sensitivity.
We
conclude
offering
comprehensive
examination
distinct
immunophenotypes
environmental
targets
geared
towards
enhancing
responsiveness
TME.
In
sum,
tailoring
precise
interventions
combination
strategies
suit
unique
TME
specific
cancers
may
herald
improved
patient
outcomes.
Cell Death and Disease,
Год журнала:
2022,
Номер
13(12)
Опубликована: Дек. 24, 2022
Abstract
Glioma
is
the
most
common
type
of
primary
malignant
tumor
in
central
nervous
system
with
limited
treatment
satisfaction.
Finding
new
therapeutic
targets
has
remained
a
major
challenge.
Ferroptosis
novel
and
distinct
programmed
cell
death,
playing
regulatory
role
progression
tumors.
However,
ferroptosis
or
ferroptosis-related
genes
(FRGs)
glioma
not
been
extensively
studied.
In
our
study,
prognostic
model,
including
7
genes,
was
established,
which
patients
classified
into
high-risk
group
had
more
immuno-suppressive
status
worse
prognosis.
Among
these
we
screened
solute
carrier
family
1
member
5
(SLC1A5),
an
FRG,
as
possible
target
for
treatment.
Our
results
showed
that
expression
SLC1A5
significantly
upregulated
glioblastoma
tissues
compared
low-grade
gliomas.
addition,
knockdown
could
inhibit
proliferation
invasion,
reduce
sensitivity
via
GPX4-dependent
pathway.
Furthermore,
found
to
be
related
immune
response
decreased
infiltration
M2
polarization
tumor-associated
macrophages.
Pharmacological
inhibition
by
V9302
confirmed
promote
efficacy
anti-PD-1
therapy.
Overall,
developed
model
based
on
seven-FRGs
signature,
apply
prediction.
Besides,
regulate
proliferation,
state
glioma,
applied
biomarker
potential
glioma.
Frontiers in Oncology,
Год журнала:
2022,
Номер
12
Опубликована: Март 17, 2022
Objective
To
clarify
the
function
and
mechanisms
of
sevoflurane
(Sev)
on
ferroptosis
in
glioma
cells.
Methods
Different
concentrations
Sev
were
used
to
treat
cells
U87
U251.
Ferroptosis
inducer
Erastin
was
incubate
combined
with
ATF4
siRNA
transfection
treatment.
CCK-8
assay
colorimetric
performed
analyze
cell
viability
Fe
+
concentration,
respectively.
The
releases
reactive
oxygen
species
(ROS)
determined
by
flow
cytometry
analysis.
Transcriptional
sequencing
screen
differential
genes
affected
U251
mRNA
protein
expression
ferroptosis-associated
detected
qRT-PCR
Western
blotting.
Results
could
suppress
viability,
increase
ROS
levels
downregulate
GPX4,
upregulate
transferrin,
ferritin,
Beclin-1
a
dose-dependent
manner
mitophagy-related
gene
activating
transcription
factor
4
(ATF4)
identified
be
enhanced
analyzed
transcriptional
sequencing.
ChaC
glutathione-specific
gamma-glutamylcyclotransferase
1
(CHAC1),
which
is
involved
ferroptosis,
downstream
ATF4.
Inhibition
interrupt
CHAC1
induced
treatment
obviously
inhibited
elevated
2+
promoted
generation
level
increased
Erastin-treated
Moreover,
interruption
Sev-induced
suppression
reversed
Erastin.
Conclusions
In
summary,
this
study
suggested
that
exposure-induced
ATF4-CHAC1
pathway
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Фев. 20, 2024
Abstract
Glioblastoma
is
a
highly
aggressive
and
malignant
type
of
brain
cancer
that
originates
from
glial
cells
in
the
brain,
with
median
survival
time
15
months
5-year
rate
less
than
5%.
Regulated
cell
death
(RCD)
autonomous
orderly
under
genetic
control,
controlled
by
precise
signaling
pathways
molecularly
defined
effector
mechanisms,
modulated
pharmacological
or
interventions,
plays
key
role
maintaining
homeostasis
internal
environment.
The
comprehensive
systemic
landscape
RCD
glioma
not
fully
investigated
explored.
After
collecting
18
RCD-related
signatures
opening
literature,
we
comprehensively
explored
landscape,
integrating
multi-omics
data,
including
large-scale
bulk
single-cell
level
lines,
proteome
data.
We
also
provided
machine
learning
framework
for
screening
potentially
therapeutic
candidates.
Here,
based
on
sequencing
samples,
phenotypes,
profile
RCD,
developed
an
gene
pair
scoring
system,
named
RCD.GP
signature,
showing
reliable
robust
performance
predicting
prognosis
glioblastoma.
Using
consisting
Lasso,
RSF,
XgBoost,
Enet,
CoxBoost
Boruta,
identified
seven
genes
as
potential
targets
verified
SLC43A3
expressed
grades
lines
through
qRT-PCR.
Our
study
insights
into
roles
glioma,
signature
patients,
constructed
core
candidates
oncogenic
prediction
biomarker
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Июль 2, 2024
Ferroptosis
induces
significant
changes
in
mitochondrial
morphology,
including
membrane
condensation,
volume
reduction,
cristae
alteration,
and
outer
rupture,
affecting
function
cellular
fate.
Recent
reports
have
described
the
intrinsic
iron
metabolism
its
intricate
connection
to
ferroptosis,
a
kind
of
cell
death
characterized
by
dependence
oxidative
stress
regulation.
Furthermore,
updated
molecular
insights
elucidated
significance
mitochondria
ferroptosis
implications
various
cancers.
In
context
cancer
therapy,
understanding
dual
role
anastasis
chemoresistance
is
crucial.
Targeting
pathways
involved
may
enhance
efficacy
inducers,
providing
synergistic
approach
overcome
chemoresistance.
Research
into
how
DNA
damage
response
(DDR)
proteins,
metabolic
changes,
redox
states
interact
during
can
offer
new
designing
combinatorial
therapeutic
regimens
against
several
cancers
associated
with
stemness.
These
treatments
could
potentially
inhibit
while
simultaneously
inducing
thereby
reducing
likelihood
cells
evading
developing
resistance
chemotherapy.
The
objective
this
study
explore
interplay
between
anastasis,
EMT
chemoresistance,
immunotherapeutics
better
understand
their
collective
impact
on
therapy
outcomes.
We
searched
public
research
databases
google
scholar,
PubMed,
relemed,
national
library
medicine
related
topic.
review,
we
discussed
tricarboxylic
acid
cycle
glycolysis
implicated
modulating
adding
complexity
regulatory
mechanisms.
Additionally,
reactive
oxygen
species
(ROS)
electron
transport
chain
(ETC)
has
garnered
attention.
Lipid
metabolism,
particularly
involving
GPX4
System
Xc-
plays
both
progression
cancer.
There
need
investigate
clinical
Integrating
strategies
targeting
exploring
potential
synergy
immunotherapy
represent
promising
avenues
for
advancing
chemoresistant
treatment.
Understanding
among
mitochondria,
ROS,
vital
oncology,
revolutionizing
personalized
treatment
drug
development.
Bosnian Journal of Basic Medical Sciences,
Год журнала:
2022,
Номер
unknown
Опубликована: Март 9, 2022
Accumulating
evidence
reveals
that
ferroptosis
and
pyroptosis
play
pivotal
roles
in
tumorigenesis
of
low-grade
glioma
(LGG).
In
this
research,
we
aimed
to
classify
molecular
subtypes
further
identify
verify
a
novel
multigene
signature
LGG
on
the
basis
pyroptosis-related
genes
(FPRGs).
Raw
sequencing
data
corresponding
clinical
samples
retrieved
from
TCGA
CGGA
databases
were
obtained
for
training
validation
datasets.
Non-negative
matrix
factorization
(NMF)
clustering
defined
by
FPRGs
associated
with
prognosis
was
performed
patients.
LASSO-SVM-Random
Forest
analysis
carried
out
develop
an
FPRG
predict
survival
benefit
immunotherapy
NMF
prognostic
values
acted
categorize
patients
into
two
different
prognosis,
traits
immune
microenvironments.
A
six-FPRG
constructed,
accompanied
optimal
p-value.
The
AUC
our
exhibited
great
performances.
Our
superior
other
four
well-recognized
signatures
predicting
probability
Immune
characteristics,
tumor
mutation
profile,
stemness
indices,
MGMT
methylation
response
biomarkers
showed
significant
differences
between
high-
low-risk
populations.
Finally,
nomogram
created
quantitative
prediction
patients,
being
0.916,
0.888
0.836
1-,
3-
5-year
survival,
sequentially.
Overall,
may
function
as
effective
indicator
Frontiers in Oncology,
Год журнала:
2022,
Номер
12
Опубликована: Апрель 28, 2022
PELATON
is
a
long
noncoding
RNA
also
known
as
intergenic
nonprotein
coding
1272
(LINC01272).
The
reports
showed
that
functions
an
onco-lncRNA
or
suppressor
lncRNA
by
suppressing
miRNA
in
colorectal
cancer,
gastric
cancer
and
lung
cancer.
In
this
study,
we
first
found
PELATON,
onco-lncRNA,
alleviates
the
ferroptosis
driven
mutant
p53
promotes
p53-mediated
GBM
proliferation.
We
confirmed
new
inhibitor
mainly
P53
mediating
ROS
pathway,
which
inhibits
production
of
ROS,
reduces
levels
divalent
iron
ions,
expression
SLC7A11,
ACSL4
COX2.PELATON
can
inhibit
wild-type
cells
regulate
BACH1
CD44,
but
it
has
no
effect
on
p53,
CD44
cells.
form
complex
through
binding
protein
EIF4A3.
Knockdown
resulted
smaller
mitochondria,
increased
mitochondrial
membrane
density,
enhanced
sensitivity
to
inducers
cell
proliferation
invasion.
addition,
established
favourite
prognostic
model
with
NCOA4
PELATON.
promising
target
for
prognosis
treatment
GBM.
Scientific Reports,
Год журнала:
2023,
Номер
13(1)
Опубликована: Окт. 20, 2023
Glioma
is
the
most
common
primary
malignant
tumor
in
central
nervous
system.
Disulfidptosis
a
recently
identified
programmed
cell
death
cells
overexpressing
SLC7A11
under
glucose
starvation.
Clinical
prognostic
significance
of
disulfidptosis
has
been
reported
several
tumors,
and
this
study,
we
explored
correlation
with
clinical
prognosis,
immune
infiltration,
immunotherapy
response
glioma.
A
total
1592
glioma
patients
were
included
including
691
from
The
Cancer
Genomic
Atlas
(TCGA),
300
Chinese
(CGGA)
array,
325
CGGA
sequencing,
276
Gene
Expression
Omnibus
(GEO)
GSE16011.
R
software
(V4.2.2)
packages
applied
to
develop
risk
score
model
calculation
visualization.
Three
disulfidptosis-related
genes,
LRPPRC,
RPN1,
GYS1,
screened
out
establish
model.
Low-risk
exhibit
favorable
signature
significantly
correlated
clinicopathological
properties,
molecular
subtypes,
immunosuppressive
microenvironment
patients.
We
developed
predict
prognosis
features
patients,
may
be
as
an
independent
factor
for